Modified fusion molecules for treatment of allergic disease
Transcrição
Modified fusion molecules for treatment of allergic disease
US 20060171942Al (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0171942 A1 (43) Pub. Date: Saxon et al. (54) MODIFIED FUSION MOLECULES FOR Aug. 3, 2006 Publication Classi?cation TREATMENT OF ALLERGIC DISEASE (51) (76) Inventors: Andrew Saxon, Santa Monica, CA (US); Ke Zhang, Los Angeles, CA (US); Daocheng Zhu, Los Angeles, CA (Us) (52) Int. Cl. A61K 39/395 00711 21/04 C12P 21/06 C07K 16/42 (2006.01) (2006.01) (2006.01) (2006.01) US. Cl. ................... ..424/133.1;435/69.1;435/328; 435/3201; 530/3872; 536/2353 (57) Correspondence Address: ABSTRACT The present invention comprises a fusion molecule com HELLER EHRMAN LLP 275 MIDDLEFIELD ROAD prising a Fce fragment sequence including functionally MENLO PARK, CA 94025-3506 (US) of an lgE heavy chain (CHe2-CHe3 -CHe4 sequence) linked active CH2, CH3 and CH4 domains of the constant region at its C-terminus to the N-terminus of a second polypeptide (21) Appl. No.: 11/050,113 including functionally active hinge, CH2 and CH3 domains of the constant region of an lgGl heavy chain (Yhinge-CHYZ Feb. 2, 2005 the fusion molecule and methods of treatment using the fusion molecule. CHy3 sequence), pharmaceutical compositions comprising (22) Filed: Patent Application Publication Aug. 3, 2006 Sheet 2 0f 19 US 2006/0171942 A1 Ala Ser 'I'hr Lys Gl'y Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser ‘Th: Ser Gly' Gly Thr Ala Ala Len‘ Gly'icys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Le'u .Thr Ser Gly Val 'His Thr' Phe Pro Ala Val 'Leu Gln Ser Ser Gly- Leu Tyr Ser Leu Ser Ser' Val Val Thr Val‘ Pro Se: Ser Ser Leu Gly 'I'hr Gln Thr ' Tyr Ile 'Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Lys .Val _Glu Pro Lys Ser Cys Asp Lys Thr His 'I'hr Cys Pro Pro. Cys Pro Ala Pro 'Gluleu Leu 6152 61y Pro Ser Val Phe Leu Phe Pro Pro ‘ Lys Val Tyr Glu H‘is' Lys Gin Leu‘ Pro Pro Lys Val Val Val’Asp Gln Tyr Gln Asn Ala Len Pro ‘Arg Thr Lys Ser Asp. Asp Asp Gly Asn Trp Thr Val Val Ser Met Ala Pro Glln' Ala Leu Ser Glu Thr Met His Val Tyr Ile Glu His Arg Asn Glly Lys Pro Pro Ile Glu Gln Val Asn Val Ser Ile Val Glu . Asn Tyr ‘Lys. 'J‘hr Thr Pro Pro ,Leu vTyr Ser Lys Leu v'I‘hr Val Val Phe Ser Cys Ser Val Met Ser' Asp Asn Va'l Glu L15 Thr Thr Glu Arg Pro Val Val Thr Glu Lys Ser Tyr Lys Pro Glu Val Lys Thr Lys Val Leu Cys- Lys Ser Lys Pro Ser. Val‘ Lys Gly- Gln Val ,Thr Ph‘e Asn Pro 'Arg Thr‘ Val Val Ser Asn Glu ‘J‘hr Ile Ala vTyr: Leu Pro Arg Leu Cys Leu G-l-y Trp Ser Asn Pro Val Leu Asp‘ Ser Val Gly Ser Asp Lys Ser Arg Trp Gln Gln' His Glu Al‘a. Leu His Asn His Gln Arg Ser Leo Ser Leu Ser Pro Gly Lys ' Cys Trp Glu ' Leu ’ Lys Asp Phe Glu ‘Val Glu Tyr Asn Phe Phe Gly Asn 'I‘yr Gln Patent Application Publication Aug. 3, 2006 Sheet 3 0f 19 US 2006/0171942 A1 Glu- Pro Lys 'Ser 'Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Gluv Leu Len Gly Gly Pro Se: Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr - Leu Met Ile Ser Arg_‘1'hr Pro Glu Val Thr'Cys val val Val Asp "I‘yr Asn Leu Arg Lys Asp Gly Asn Trp Pro 611: Asn Val Val Ser Met Ala Pro Gln Ser His 6111 Val Thr Tyr Asn‘ Gly -Pro\Ile Gln Val Val S‘er Glu His Arg Lys Glu Tyr Leu Asp'Pro Asn Val Val V'al Glu 'I‘yr Lys Thr Thr Lei: Thu-r Cys Glu Lys Ser Lys Ile Pro Leu Val Thr Val Cys Ser Pro Val Lys Lys' Leu -Lys~ Lys Ser Lys Phe Pro Thr Val Ala Arg Gly Asn :I‘rp Tyr Arg' Glu G111 Val Leu 'His Ser Asn Lys Lys Val',Gln AspGlu Leu Phe Tyr Pro Val G111 Gln Ala Pro Thr Se: Asp Ile Ala Val Glu 'I‘rp Glu Ser'Asn Gly Gl'n Pro Glu Asn ' Asn 'Iyr Ly's Thr' 'I‘hr ‘Pro Pro Val Len Asp Ser Val Gly Ser Phe Phe Leu Tyr S_er Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln G'ly Asn Val Phe Ser Cys' S‘e-r Val Met His Gin Ala’ Leu His Asn His Tyr Gln Gln Arg .Ser vLou 'Ser Len Ser Pro Gly Ly; ' ' Patent Application Publication Aug. 3, 2006 Sheet 5 0f 19 I Ser Ile 'I'yr Gly Tyr Met Asp Thr Pro Phe Thr Ala Phe Asn Gln Ser Pro “Thr Thr Thr Lys ~ 'Ser Asn 6111 Met Ile Cys Thr US 2006/0171942 A1 " “FIGURE 5 Pro Ser Val Phe Pro Leu Thr Arg Cys Cys Lys Asn Ala Thr Ser Val Thr Leu Gly Cys Leu Ala Thr Gly Pro Thr Ser' Arg Phe Val Leu Leu Val Ser Met Pro Leu Ala Val Val-Thr Ala Thr Thr Val His Thr C'ys Ser Trp Thr Ser Pro Arg Asp Leu Gly Ser .Asp Thr Thr Ala Ser Phe Gly Len Trp' Thr Thr Ser Ser Ala Asp Pro Leu Gly Lys ".l‘rp Pro Asn His Gln . Val -‘ Thr Val Lys ‘Ile Leu Gln Ser Ser'Cys Asp Gly Gly Gly His Phe' ‘Pro Pro Thr Ile Gln 'Leu Leu Cys Leu Val 'Ser Gly Tyr Thr Pro Gly Thr Ile Asn ‘Ile Thr Trp Len Glu Asp Gly Gln Val Met Asp Val Asp Leu Ser Thr Al'a Leu Thr Gln Val Ala AspPro Phe Val' Asp Ala Ser Arg Asn _' Asp'Trp Leu. Pro Ala Ala Arg ‘Asp Asp Ile Arg His val Phe Glu Phe Ser Thr Leu Ser Thr '_I‘yr Ser Asn Asp Leu Leu Ala Gly' Lys Gly Thr Ile Glu Arg Ala Pro Glu Lys Arg Ser'Val Ser Thr Ser Arg Ile Cys Thr Gln Gln Pro Phe Pro Pro Leu Gly Leu Val Thr Gln Thr Leu Arg Gln Glu Gly Glu Lys His 'J‘rp Leu Gly His Thr Phe Arg Gl'y Val Ser lle Arg Lys Ser Ser Lys Gly Thr Val Asn His Ser Thr ‘Val Thr Ser Glu Thr Tyr Gln Met Argv Ser Thr Tyr Ala Phe' Ala Leu Ala ,Cys Leu Trp Leu ‘His Asn v(Sln Pro Arg Lys 611.: Val "I‘hr' Arg' Ala Val ‘His Glu Leu Ala Ser 'I'hr Gln 'Ser Glu Ser Asp Arg Thr Tyr Thr, Cys Glu Ala Pro Val Thr Thr Cys Thr Thr Ile Glu Thr ‘Ala _-Ala Asp Ty: Thr Asn Arg Leu' Arg Ser Leu Ile Leu Lys Pro Val Thr Lys 'Lys Ser Arg Pro Thr Cys Leu Thr -Trp Ser G11: G11: Lys Val Gly. Thr Thr His Pro Cys Se: val Arg Gln Arg His Lys Pro Gln Val Lys Thr‘ Glu Asn Gln Gly Ser Trp Phe Len Ser Arg Ser Glu Ala Phe Gly Pro Met Pro Gly Pro Gly Pro Asp Phe. Glu Trp Glu Gln Lys Asp Ala Ser Pro Ser 6111 Thr Val Gln Arg Ala Val Ser Val As‘n Pro Gly Lys ' ‘ Patent Application Publication Aug. 3, 2006 Sheet 6 0f 19 US 2006/0171942 A1 FIGURE6. Phe Thr Pro Pro Thr Val Lys Ile‘ Leu Gln Ser Ser Cys Asp Gly Gly Glyv His Phe Pro Pro Thr Ile Gln Leu Leu Cys L‘eu Val. Ser Gly Tyr Thr' Pro Gly_'Thr Ile Asn Ile Thr _Trp Leu Glu Asp Gly_ Gln Val Met . Asp Val Asp Leu Ser Thr Ala Ser Thr 'Thr Gln 611: Gig Gl'u .Leu Ala so: Thr Gl'n Ser Glu Leu Thr Leu Ser Gln Lys His Trp Leu Ser Asp Arg Ser Leu Ile Leu Lys Th-r Thr Ser Thr 'Thr Gl-u 'I'yr Lys Arg 'Cys Thr Lys Pro .L'eu Cys Cys Ser Val Trp Ser Arg Glu Lys Gln' Gln Ala Pro Val Val Asp Phe Asp Ala Ser Arg Asn Thr Ser Asp Len .6151 Gly Tyr Asn Leu Ala Gln Pro Phe Pro Lys Pro Thr Leu Gly Arg ‘Ile Se: His Gly Arg Lys Val Asn 'I'hr Val Thr Val Lys Gly Phe w Glu S'er Ala Ser. Pro Thr val Asp_ Tyr _ Thr Asn ' 315' Ser. Thr Arg Thr Seerw Thr Leu Pro Val Gly Thr Arg Asp Trp Ile Glu Gly Glu Thr Tyr Gln Cys Arg Val Thr His Pro Hi's Leu Pro Arg Ala ~Leu Met Arg Ser Th: Th: Lys Thr Ser Gly Pro Arg Ala Ala Pro Glu Val 'Iyr Ala Phe Ala Th: Pro Glu T'rp‘vPro Gly Ser Arg As'p Lys Arg Thr L_eu Ala, Cys Leu Ile 6111 A511 Phe Met Pr‘o Glu Asp Ile Ser val Gln Trp Leu His Asn Glu Val .Gln Len Pro ‘Asp Alaw Arg His Ser Thr Thr Gln Pro Arg Lys Thr ‘Lys I Gly Ser Gly Phe Phe \fal Phe Ser Ar-g Leu Glu Val T-hr Arg Ala Glu I - TrpGlu Gln Lys Asp Glu Phe Ile Cys'Arg Ala Val His Glu Ala Al‘a 'S_er Pro Ser Gln Thr Val Gln Arg Ala Val Ser Val Asn Pro Gly Lys Patent Application Publication Aug. 3, 2006 Sheet 12 0f 19 US 2006/0171942 A1 FIGURE 9B: GE2 S mutant DNA and Protein Sequence 1 0 a 1 GACAGCACCAAGAAGTGTGCAGATTCCAACCCGAGAGGGGTGAGCGCCTACCTAAGCCGG 361DSTKKCADSNPRGVSAYLSR 1141 CCCAGCCCGTTCGACCTGTTCATCCGCAAGTCGCCCACGATCACCTGTCTGGTGGTGGAC 381 P S P F D L F I R K S P T I T C L V V D 1201 CTGGCACCCAGCAAGGGGACCGTGAACCTGACCTGGTCCCGGGCCAGTGGGAAGCCTGTG 401 L A P S K G T V N L T W S R A S G K P V 1261 AACCACTCCACCAGAAAGGAGGAGAAGCAGCGCAATGGCACGTTAACCGTCACGTCCACC 421 N H S T R K E E ‘K Q R N G T L T V T S T 1321 CTGCCGGTGGGCACCCGAGACTGGATCGAGGGGGAGACCTACCAGTGCAGGGTGACCCAC 441 1381 461 L P V G T R D W I E G E T Y Q C R V T H CCCCACCTGCCCAGGGCCCTCATGCGGTCCACGACCAAGACCAGCGGCCCGCGTGCTGCC P H L P R A L M R S T T K T- S G P R A A 1441 CCGGAAGTCTATGCGTTTGCGACGCCGGAGTGGCCGGGGAGCCGGGACAAGCGCACCC(TC 481 0 P E V Y A F A T P E W P G S R D K R T L 1501 GCCTGCCTGATCCAGAACTTCATGCCTGAGGACATCTCGGTGCAGTGGCTGCACAACGAG 501 A C L I Q N F M P E D I S V Q W L H N E 1561 GTGCAGCTCCCGGACGCCCGGCACAGCACGACGCAG-CCCCGCAAGACCAAGGGCTCCGGC 521 V Q L P D A R H S T T Q P R K T K G S G 1621 TTCTTCGTCTTCAGCCGTCTAGAGGTGACCAGGGCCGAATGGGAGCAGAAAGATGAGTTC 541, F F V F S R L E V T R A E W E Q K D E F 1681 ATCTGCCGTG'CAGTCCATGAGGCAGCTAGCCCCTCACAGACCGTCCAGCGAGCGGTGTCT 561 I C R A V H 1741 GTAAATCCCGGTAAATGA 581 V N P G K * E A A S P S Q T V Q R A V S 1 14 o 380 1200 400 1260 420 1320 440 1380 460 I 1440 480 1500 500 1560 520 1620 540 1680 560 1740 580 1758 586 Patent Application Publication Aug. 3, 2006 Sheet 14 0f 19 US 2006/0171942 A1 FIGURE 10B: GEZ H mutant DNA and Protein Sequence 1081 GACAGCACCAAGAAGTGTGCAGATTCCAACCCGAGAGGGGTGAGCGCCTACCTAAGCCGG 361 D S T K K C A D S N P R G V S A Y L S R 1141 CCCAGCCCGTTCGACCTGTTCATCCGCAAGTCGCCCACGATCACCTGTCTGGTGGTGGAC 381 P S P F D L F I R K S P T I T C L V V D 1201 CTGGCACCCAGCAAGGGGACCGTGAACCTGACCTGGTCCCGGGCCAGTGGGAAGCCTGTG 401 L A P S K G T V N L T W S R A S G K P V 1261 AACCACTCCACCAGAAAGGAGGAGAAGCAGCGCAATGGCACGTTAACCGTCACGTCCACC 421 N H S T R K E E K Q R ' N G T L T V T S T 1321 CTGCCGGTGGGCACCCGAGACTGGATCGAGGGGGAGACCTACCAGTGCAGGGTGACCCAC 441 L P V G T R D W I E G E T Y Q C R V T H 1381 CCCCACCTGCCCAGGGCCCTCATGCGGTCCACGACCAAGACCAGCGGCCCGCGTGCTGCC 461 P H L P R A L M R S T T K T S G P R A A 1441 CCGGAAGTCTATGCGTTTGCGACGCCGGAGTGGCCGGGGAGCCGGGACAAGCGCACCCTC 481 P E V Y A F A T P E W P G S R D K R T L 1501 GCCTGCCTGATCCAGAACTTCATGCCTGAGGACATCTCGGTGCAGTGGCTGCACAACGAG 501 A C L I Q N F M P E D I S V Q W L H N E 1561 GTGCAGCTCCCGGACGCCCGGCACAGCACGACGCAGCCCCGCAAGACCAAGGGCTCCGGC 521 V Q L P D A R H S T T Q P R K T K G S G 1621 TTCTTCGTCT'I‘CAGCCGTCTAGAGGTGACCAGGGCCGAATGGGAGCAGAAAGATGAGTTC 541 F F V F S R L E V T R A E W E Q K D E F 1681 ATCTGCCGTGCAGTCCATGAGGCAGCTAGCCCCTCACAGACCGTCCAGCGAGCGGTGTCT 561 I C R A V H 1741 GTAAATCCCGGTAAATGA 581 V N P G K * E A A S P S Q T V Q R A V S 1140 380 1200 400 1260 420 1320 I 440 1380 460 1440 480 1500 500 1560 520 1620 540 1680 560 1740 580 1758 586 Patent Application Publication Aug. 3, 2006 Sheet 15 0f 19 “=8~9583.2635.m. .. m6. .v . ‘F .m.mg 0. no.2 2..5325.0 . .. .2: . ‘. US 2006/0171942 A1 v20.c35 5 =3:E;N8.aPrH5§i=kwvU9-aE.5i%03 owTzgeM\?ouM8w.. o 6 u. m. u m... .3:V. .HEM Patent Application Publication Aug. 3, 2006 Sheet 16 0f 19 256%13 15m:m 8.+3.5w .mwim :5? 2m m +E om . +63%‘, 285:m» m6 83mm + . mEm: .+62% Sm2&13 8+5.6w US 2006/0171942 A1 @SE?H 8+2m we?SoA. Patent Application Publication Aug. 3, 2006 Sheet 17 0f 19 US 2006/0171942 Al . +E .om. “no+E5§.35m1 32063, 5?m.. +...2aéEimwu:mi . w w~.vi.mwi\wi.v_wo,. ..Swéuf. Patent Application Publication Aug. 3, 2006 Sheet 18 0f 19 83+0m. 8o52n3em8.0?. +.E: 5m US 2006/0171942 A1 15.»: #Scm~.326 ‘+63% . ... .‘ 3.? 8w 2,Haul? .m6ams? fméw [email protected]_3 6.20m +. ... _...825%~.. +E om. Patent Application Publication Aug. 3, 2006 Sheet 19 0f 19 US 2006/0171942 A1 wm w VSH-HN-I-HEISU EgaKunw-QsEi.I»:BH 5$2685.E25S3E%;:“
Documentos relacionados
MolProbity Ramachandran analysis
BC 117 SER (175.5, 8.0) BC 121 ALA (39.2, -153.7) BC 123 ILE (-40.0, 97.2) BC 135 PRO (-56.9, -147.8) BC 140 VAL (47.8, -144.0) BC 141 HIS (178.0, -122.1) BC 145 MET (-47.3, -85.6) BC 149 LYS (-39....
Leia mais